Renaissance Capital logo

PGEN News

An unmet need for knees: Biotech Histogenics sets terms for $60 million IPO

Histogenics, a biotech developing a therapy for repairing knee cartilage using its tissue repair platform, announced terms for its IPO on Friday. The Waltham, MA-based company plans to raise $60 million by offering 4.3 million shares at a price range of $13 to...read more

US IPO Recap: Nine deals price, Intrexon and Cvent soar

Despite a downturn in the markets last week, the IPO market surged ahead, with nine deals pricing and two gaining more than 50%. Six of last week’s deals priced...read more

Intrexon prices upsized IPO at $16, the high end of the range

XON

Intrexon, which is developing synthetic biology technologies to improve drugs and food, raised $160 million in an upsized IPO by offering 10.0 million shares at $16, the high end of the range of $14 to $16. The company had originally planned to offer 8.3 million...read more

US IPO Recap: Six deals price, heavy deal flow continues into August

AMH

The US IPO market continued at a quick pace last week, with six deals raising over $1.6 billion. Sprouts Farmers Market (SFM) was the week’s winner with a 123% first-day pop, the best first-day return since March 2011. Control4 (CTRL) and Athlon Energy...read more